Syros Pharmaceuticals, Inc.: Nasdaq/NYSE listing notice — Syros receives Nasdaq deficiency notices for bid price, market value of listed securities, and publicly held shares

Syros Pharmaceuticals, Inc.

Bid price closed below $1.00 for 35 consecutive days; 180-day cure period until July 7, 2025.
Minimum Value of Listed Securities (MVLS) below $50M for 30 consecutive business days.
Market Value of Publicly Held Shares (MVPHS) below $15M for 35 consecutive business days.
To regain compliance, stock must close at $1.00+ for 10 days; MVLS at $50M+; MVPHS at $15M+.
May transfer to Nasdaq Capital Market or appeal delisting if non-compliance continues.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Syros Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A), 5450(b)(2)(C)

Exact text from the filing

January 6, 2025, Syros Pharmaceuticals, Inc. (“ Syros ”) received deficiency letters (the “ Notices ”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“ Nasdaq ”) notifying Syros that: • for the last 35 consecutive business days, the bid price for Syros’ common stock has closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Requirement ”); • for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defin

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Syros Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

January 6, 2025, Syros Pharmaceuticals, Inc. (“ Syros ”) received deficiency letters (the “ Notices ”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“ Nasdaq ”) notifying Syros that: • for the last 35 consecutive business days, the bid price for Syros’ common stock has closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Requirement ”); • for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defin

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-25-003483

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.